Published in Neuroscience on January 01, 2001
p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS. Open Pathol J (2010) 0.80
Aromatase in human liver and its diseases. Cancer Med (2013) 0.76
Stem cell-derived astrocytes: are they physiologically credible? J Physiol (2016) 0.76
Intestinal inflammatory pseudotumour with regional lymph node involvement: identification of a new bacterium as the aetiological agent. J Pathol (2000) 3.20
beta1-integrin is dispensable for the induction of ErbB2 mammary tumors but plays a critical role in the metastatic phase of tumor progression. Proc Natl Acad Sci U S A (2010) 1.40
Nutrient release and sediment oxygen demand in a eutrophic land-locked embayment in Hong Kong. Environ Int (2001) 1.23
Proteolytic enzymes of Neurospora crassa. Purification and some properties of five intracellular proteinases. Eur J Biochem (1975) 1.03
Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity: implications for advanced glycation and diabetic complications. Diabetologia (1997) 1.00
Prevention of cannabinoid withdrawal syndrome by lithium: involvement of oxytocinergic neuronal activation. J Neurosci (2001) 1.00
Oxidative deamination of methylamine by semicarbazide-sensitive amine oxidase leads to cytotoxic damage in endothelial cells. Possible consequences for diabetes. Diabetes (1993) 0.98
Studies on the apparent instability of Neurospora tryptophan synthase. Evidence for protease. Eur J Biochem (1973) 0.98
Inapparent infection of hepatitis A virus. Am J Epidemiol (1988) 0.97
Dopamine- and L-beta-3,4-dihydroxyphenylalanine hydrochloride (L-Dopa)-induced cytotoxicity towards catecholaminergic neuroblastoma SH-SY5Y cells. Effects of oxidative stress and antioxidative factors. Biochem Pharmacol (1997) 0.96
Irreversible inhibition of monoamine oxidase by some components of cigarette smoke. Life Sci (1987) 0.96
Differential effects of staurosporine and retinoic acid on the vulnerability of the SH-SY5Y neuroblastoma cells: involvement of bcl-2 and p53 proteins. J Neurosci Res (1999) 0.94
Gradation of kainic acid-induced rat limbic seizures and expression of hippocampal heat shock protein-70. Eur J Neurosci (1997) 0.93
Rescue of axotomized immature rat facial motoneurons by R(-)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J Neurosci (1993) 0.90
Studies on the pargyline-binding site of different types of monoamine oxidase. Can J Biochem (1981) 0.90
Patterns of shedding of hepatitis A virus antigen in feces and of antibody responses in patients with naturally acquired type A hepatitis. J Infect Dis (1980) 0.90
Susceptibility of monkeys to human hepatitis A virus. J Infect Dis (1981) 0.88
Stereospecific deuterium substitution at the alpha-carbon position of dopamine and its effect on oxidative deamination catalyzed by MAO-A and MAO-B from different tissues. Biochem Pharmacol (1986) 0.85
Comparison of cytotoxicity of a quaternary pyridinium metabolite of haloperidol (HP+) with neurotoxin N-methyl-4-phenylpyridinium (MPP+) towards cultured dopaminergic neuroblastoma cells. Psychopharmacology (Berl) (1995) 0.85
The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol Appl Neurobiol (2007) 0.84
Formation of formaldehyde from adrenaline in vivo; a potential risk factor for stress-related angiopathy. Neurochem Res (1997) 0.83
Radioenzymatic estimation of S-adenosylmethionine in rat brain regions and subcellular fractions. Anal Biochem (1978) 0.83
Effect of L-deprenyl, its structural analogues and some monoamine oxidase inhibitors on dopamine uptake. Neuropharmacology (1994) 0.83
Formaldehyde produced endogenously via deamination of methylamine. A potential risk factor for initiation of endothelial injury. Atherosclerosis (1996) 0.83
Chronic L-deprenyl or L-amphetamine: equal cognitive enhancement, unequal MAO inhibition. Pharmacol Biochem Behav (1994) 0.83
Characterization of human serum and umbilical artery semicarbazide-sensitive amine oxidase (SSAO). Species heterogeneity and stereoisomeric specificity. Biochem Pharmacol (1994) 0.82
Effects of yeast proteinase and its inhibitor on the inactivation of tryptophan synthase from Saccharomyces cerevisiae and Neurospora crassa. Eur J Biochem (1973) 0.82
Effect of aldehydes derived from oxidative deamination and oxidative stress on beta-amyloid aggregation; pathological implications to Alzheimer's disease. J Neural Transm (Vienna) (2007) 0.82
Activation of platelet monoamine oxidase by plasma in the human. Life Sci (1979) 0.82
Some observations on the interaction of dopamine-beta-hydroxylase and its natural inhibitors in the rat brain. Can J Biochem (1976) 0.81
Biogenic amine adducts, monoamine oxidase inhibitors, and smoking. Lancet (1988) 0.81
Removal and recovery of copper (II) ions by bacterial biosorption. Appl Biochem Biotechnol (2001) 0.81
Expression of heat shock protein-70 and limbic seizure-induced neuronal death in the rat brain. Eur J Neurosci (1996) 0.81
Sub-lethal effects of heavy metals on activated sludge microorganisms. Chemosphere (1999) 0.80
Hyperproduction of polyesters consisting of medium-chain-length hydroxyalkanoate monomers by strain Pseudomonas stutzeri 1317. Antonie Van Leeuwenhoek (2000) 0.80
A novel magnetite-immobilized cell process for heavy metal removal from industrial effluent. Appl Biochem Biotechnol (2000) 0.80
Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase. Anal Biochem (1999) 0.80
R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells. Toxicol Appl Pharmacol (1997) 0.80
A behavioural and neurochemical analysis of chronic and selective monoamine oxidase inhibition. Psychopharmacology (Berl) (1987) 0.80
Studies in monkeys of attenuated hepatitis A variants. Sci Sin B (1988) 0.80
Follow-up of plasma semicarbazide-sensitive amine oxidase activity and retinopathy in Type 2 diabetes mellitus. J Diabetes Complications (2001) 0.79
On the stoichiometry and reversibility of interaction between Neurospora protease I and its inhibitor. FEBS Lett (1974) 0.79
Deuterium isotope effect in gamma-aminobutyric acid transamination: determination of rate-limiting step. J Neurochem (1987) 0.79
Specific photoactivated covalent binding of S-adenosylmethionine to phenylethanolamine-N-methyl transferase. Biochim Biophys Acta (1983) 0.79
N-acylation of tyramines: purification and characterization of an arylamine N-acetyltransferase from rat brain and liver. Can J Biochem (1979) 0.79
Induction of preconvulsive behavior and Fos expression by dopamine-induced nigral lesion in the rat. Brain Res (1997) 0.78
Simultaneous determination of formaldehyde and methylglyoxal in urine: involvement of semicarbazide-sensitive amine oxidase-mediated deamination in diabetic complications. J Chromatogr Sci (1999) 0.78
Effects of trace levels of copper, chromium, and zinc ions on the performance of activated sludge. Appl Biochem Biotechnol (2000) 0.78
The management of isolated thrombocytopenia in Chinese adults: does bone marrow examination have a role at presentation? Clin Lab Haematol (2000) 0.78
Isolation of specific protease inhibitors from Neurospora crassa. Can J Biochem (1976) 0.78
Enhanced tolerance of neuroblastoma cells towards the neurotoxin 6-hydroxydopamine following specific cell-cell interaction with primary astrocytes. Neuroscience (1997) 0.78
Type A and B monoamine oxidase in glial cells in long-term culture. Prog Neuropsychopharmacol Biol Psychiatry (1983) 0.77
Determination of tissue S-adenosylmethionine by radioenzymatic assay. Methods Enzymol (1983) 0.77
Biosynthesis of enkephalins by chromaffin cells of bovine adrenal medulla. Biochem Biophys Res Commun (1980) 0.77
Enhancement of 5-HT-induced anorexia: a test of the reversibility of monoamine oxidase inhibitors. Psychopharmacology (Berl) (1989) 0.77
Differential expression of type A and type B monoamine oxidase of mouse astrocytes in primary cultures. J Neurochem (1982) 0.77
Monoamine oxidase in young and adult rat brain capillaries. J Neural Transm (1984) 0.77
Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications. J Neural Transm Suppl (1994) 0.77
Accumulation of biodegradable copolyesters of 3-hydroxy-butyrate and 3-hydroxyvalerate in Alcaligenes eutrophus. Appl Biochem Biotechnol (1998) 0.77
Monoamine oxidase-B inhibition: a comparison of in vivo and ex vivo measures of reversible effects. J Neural Transm (1988) 0.77
Prevention of kainic acid-induced limbic seizures and Fos expression by the GABA-A receptor agonist muscimol. Eur J Neurosci (1997) 0.77
Microbial production of polyhydroxyalkanoates by bacteria isolated from oil wastes. Appl Biochem Biotechnol (2000) 0.77
The preparedness of Hong Kong medical students towards advance directives and end-of-life issues. East Asian Arch Psychiatry (2010) 0.77
Inhibition of a type B monoamine oxidase inhibitor, (E)-2-(4-fluorophenethyl)-3-fluoroallylamine (MDL-72974A), on semicarbazide-sensitive amine oxidases isolated from vascular tissues and sera of different species. Biochem Pharmacol (1992) 0.77
Modeling and optimization of enantioseparation by capillary electrochromatography. Anal Chem (1998) 0.76
The effect of L-deprenyl on behavior, cognitive function, and biogenic amines in the dog. Neurochem Res (1993) 0.76
Deamination of methylamine and aminoacetone increases aldehydes and oxidative stress in rats. Life Sci (1998) 0.76
Platelet monoamine oxidase activity and trace acid levels in plasma of agoraphobic patients. Acta Psychiatr Scand (1983) 0.76
Potentiation of the biochemical effects of beta-phenylethylhydrazine by deuterium substitution. Biochem Pharmacol (1983) 0.76
Induction of subcutaneous adipose proliferation by olanzapine in rodents. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.76
Lesion of the substantia nigra pars compacta downregulates striatal glutamate receptor subunit mRNA expression. Brain Res (1999) 0.76
Longitudinal effect of amitriptyline and fluoxetine treatment on plasma phenylacetic acid concentrations in depression. Biol Psychiatry (1991) 0.76
Neuroprotection by R(-)-deprenyl and N-2-hexyl-N-methylpropargylamine on DSP-4, a neurotoxin, induced degeneration of noradrenergic neurons in the rat locus coeruleus. Neurosci Lett (1995) 0.76
[Environmental investigation in areas where Anopheles anthropophagus distributed in Hubei Province]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (2001) 0.76
Effect of haloperidol and its metabolites on dopamine and noradrenaline uptake in rat brain slices. Psychopharmacology (Berl) (1995) 0.76
Semicarbazide-sensitive amine oxidase and mortality in chronic heart failure. Eur Heart J (2000) 0.75
Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sclera. Brain Res Bull (1994) 0.75
Phenelzine reduces plasma vitamin B6. J Psychiatry Neurosci (1994) 0.75
Deuterium-labelled p-tyramine challenge test and phenolsulfotransferase activity in depressed patients--failure to replicate decreased p-tyramine conjugation in depression. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.75
High-performance liquid chromatographic procedure for the simultaneous determination of aromatic L-amino acid decarboxylase activity towards 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan. J Chromatogr (1991) 0.75
Fos oncoprotein expression in the rat forebrain following muscimol-induced absence seizures. Neurosci Lett (1996) 0.75
Apparent differences in tryptophan hydroxylation by cockroach (periplaneta americana) nervous tissue and rat brain. Neurochem Int (1987) 0.75
Granulocytic sarcoma of the uterus complicating myelodysplastic syndrome. Am J Hematol (1996) 0.75
Inhibition of MAO-B by (-)-deprenyl alters dopamine metabolism in the macaque (Macaca facicularis) brain. Neurochem Res (1995) 0.75
Kidney lipids: changes caused by dietary 9-trans, 12-trans-octadecadienoate. Lipids (1979) 0.75
[Determination of 10-hydroxy-trans-2-decenoic acid (10-HDA) in royal jelly by gas liquid chromatography]. Zhong Yao Tong Bao (1987) 0.75
Development of monoamine oxidase activity and monoamine effects on glutamate release in cerebellar neurons and astrocytes. Neurochem Res (1989) 0.75
MK-801 induces apoptotic neuronal death in the rat retrosplenial cortex: prevention by cycloheximide and R(-)-2-hexyl-N-methylpropargylamine. J Neurosci Res (1996) 0.75
Studies on the properties of some peripheral MAO inhibitors. Prog Neuropsychopharmacol Biol Psychiatry (1991) 0.75
Increase of survival of dopaminergic neuroblastoma in co-cultures with C-6 glioma by R-(-)-deprenyl. Prog Brain Res (1995) 0.75
Longitudinal study of inmates of a prison for the psychiatrically disturbed: plasma concentrations of biogenic amine metabolites and amino acids. Psychiatry Res (1991) 0.75
Depletion of NOS activity in the rat dentate gyrus neurons by DSP-4 and protection by deprenyl. Brain Res Bull (1995) 0.75
Effects of chronic oral administration of L-deprenyl in the dog. Pharmacol Biochem Behav (1995) 0.75
Circulating leukocytes with ingested mucin in a child with Hirschsprung's disease. Am J Hematol (1996) 0.75
Immunohistochemical evidence of neuroprotection by R(-)-deprenyl and N-(2-hexyl)-N-methylpropargylamine on DSP-4-induced degeneration of rat brain noradrenergic axons and terminals. J Neurosci Res (1996) 0.75